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ABSTRACT
Introduction: Patients with colorectal cancer report
ongoing physical and psychological impairments and a
high proportion of these patients are overweight,
insufficiently active and high-risk drinkers, putting
them at risk of poor recovery and risk of recurrence
and comorbidities. A challenge is implementing
sustainable and effective rehabilitation as part of
routine care for this group.
Methods and analysis: A two-arm pilot randomised
controlled trial (RCT) with embedded feasibility study
undertaken as a phased programme of work. The
intervention involves an existing cardiac rehabilitation
programme for cardiac patients accepting colorectal
cancer patient referrals. The intervention consists of
supervised exercise sessions run by a cardiac
physiotherapist and information sessions. Phase 1 will
involve one research site enrolling 12 patients to
assess intervention and study design processes.
Semistructured interviews with patients with colorectal
cancer and cardiac patients and clinicians will be used
to gather data on acceptability of the intervention and
study procedures. Phase 2 will involve three sites
enrolling 66 patients with colorectal cancer randomised
to control or intervention groups. Outcome measures
will be taken preintervention and postintervention, for
phases 1 and 2. The primary outcome is accelerometer
measured physical activity; secondary outcomes are
self-report physical activity, quality of life, anxiety,
depression, symptoms including fatigue. The following
variables will also be examined to determine if these
factors influence adherence and outcomes: self-
efficacy, risk perception and treatments.
Ethics and dissemination: Full ethical approval was
granted by NRES Committees—North of Scotland
(13/NS/0004; IRAS project ID: 121757) on 22 February
2013. The proposed work is novel in that it aims to
test the feasibility and acceptability of using an
evidence-based and theory driven existing cardiac
rehabilitation service with patients with colorectal
cancer. Should this model of rehabilitation prove to be
clinically and cost effective we aim to conduct a
randomised controlled trial of this intervention to
measure effectiveness.
Trial registration reference: ISRCTN63510637;
UKCRN id 14092.
INTRODUCTION
Over two million people are living with
cancer in the UK, and this number is rising
by 3% per annum1 and includes approxi-
mately 150 000 people diagnosed with colo-
rectal cancer.2 Increasing incidence and
survival, and a growing awareness of the
physical and psychological long-term and
late-term effects of cancer and its treat-
ments,3 means that there is growing demand
for rehabilitation. Recent evidence presents a
strong case for the provision of rehabilitation
services for patients with colorectal cancer.
Around 30% of patients with colorectal
cancer report on-going physical and psycho-
logical impairments.3 4 A high proportion
Strengths and limitations of this study
▪ This is the first study to test the feasibility and
acceptability of cardiac rehabilitation for patients
with colorectal cancer.
▪ The study will also test if it is feasible and
acceptable to deliver rehabilitation to mixed clin-
ical population groups (ie, mycardial infarction
and colorectal cancer).
▪ This is a pilot randomised controlled trial with an
embedded feasibility study and therefore will not
report on the effectiveness of cardiac rehabilita-
tion for patients with colorectal cancer.
Munro J, Adams R, Campbell A, et al. BMJ Open 2014;4:e004684. doi:10.1136/bmjopen-2013-004684 1
Open Access Protocol
group.bmj.com on May 25, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
are overweight, insufﬁciently active and high-risk drin-
kers,5 putting them at risk of poor recovery and risk of
recurrence and comorbidities. Yet, colorectal cancer sur-
vivors report among the lowest physical activity participa-
tion rates of any cancer survivor group6 and have been
shown to perform considerably less physical activity after
their diagnosis than they did before. This suggests
potential room for improvement in levels of physical
activity if given appropriate support.
Observational studies have highlighted the beneﬁt of
exercise (a core component of cardiac rehabilitation)
for colorectal cancer survivors. In a study involving 832
people with stage iii colon cancer indicated that higher
levels of self-reported physical activity approximately
6 months after completion of chemotherapy were asso-
ciated with superior disease-free, recurrence-free and
overall survival.7 A study of 668 men diagnosed with
stages i–iii colorectal cancer also found that increased
physical activity was signiﬁcantly associated with
improved colorectal cancer-speciﬁc mortality and overall
mortality.8 These observational studies suggest that inter-
ventions to increase physical activity in colorectal cancer
survivors may help to improve disease outcomes.
Moreover, it has been suggested that the magnitude of
the associations between physical activity and disease
outcomes reported in these observational studies com-
pares favourably with the beneﬁt observed with the use
of adjuvant chemotherapy, but would likely involve lower
toxicity and cost.9
Five recent systematic reviews of controlled trials indi-
cate that physical activity interventions can help address
the physiological and psychosocial effects of cancer and
associated treatments in adult patients with cancer.10–14
While together these reviews demonstrate the beneﬁts
of exercise interventions, a note of caution is required
because the results of these studies cannot be automatic-
ally generalised to patients with colorectal cancer. This is
because patients with colorectal cancer relative to
patients with breast cancer (the most featured group of
patients in reviewed studies) present with more
advanced disease, have different treatments and symp-
toms,tend to be older and include equal numbers of
men and women.
Cardiac rehabilitation may be an appropriate form of
rehabilitation for patients with colorectal cancer because
many of their needs post-treatment are similar to those
individuals living with coronary heart disease. Studies on
patients’ experiences of needs after coronary artery
bypass grafting15–18 and patients with colorectal
cancer19 20 indicate that patients with cardiac issues and
cancer experience similar problems including pain,
fatigue, anxiety and depression, worry, appetite loss,
sexual problems, sleep disturbance, and work and
ﬁnancial-related difﬁculties and express a need for infor-
mation about medication and self-management. Thus,
the rehabilitation needs of patients with coronary heart
disease and patients with colorectal cancer are likely to
be similar. Pointing out the similarities in post-treatment
experiences is not to deny that disease-related differ-
ences exist. Patients with colorectal cancer may speciﬁc-
ally experience physical discomfort and bowel function
problems and urinary tract infections and need advice
about abdominal pain and stoma care.21 22 The compara-
tive evidence, however, suggests that a common rehabili-
tation programme may be appropriate for meeting many
of the needs of both groups. Moreover, cardiac rehabilita-
tion may be particularly relevant for patients with colorec-
tal cancer since the estimated prevalence of
cardiovascular disease is 59% at 5 months postdiagnosis
and 16% develop de novo cardiovascular disease within
36 months after treatment.23 Thus, this is why a study
exploring the feasibility and acceptability of delivering
cardiac rehabilitation to mixed classes of patients with
cardiac issues and colorectal cancer with some disease-
speciﬁc components delivered by experts in cardiac and
cancer care, respectively, seems worthwhile.
AIMS AND OBJECTIVES
The purpose of the study is to conduct a pilot rando-
mised controlled trial (RCT) of an existing cardiac
rehabilitation service versus usual care (no routine
National Health Service (NHS) rehabilitation provision)
to aid the recovery of patients with colorectal cancer.
The pilot RCT with embedded feasibility study will be
conducted to inform the design and conduct of a future
larger scale effectiveness trial for which separate funding
would be required.
The overall aims of this essential preliminary work are to:
1. Assess the potential of an existing cardiac rehabilita-
tion service taking colorectal cancer patient referrals
to improve health outcomes for patients with cancer.
2. Reﬁne the intervention and trial procedures for a
future full-scale effectiveness RCT.
Phase 1: feasibility study objectives
1. To assess the feasibility of delivering rehabilitation to
patients with cancer within a cardiac rehabilitation
setting.
2. To assess the acceptability of the intervention for
patients and clinicians (cancer and cardiac).
3. To assess the acceptability and adequacy of the train-
ing and support provided by a cancer-exercise spe-
cialist for cardiac physiotherapists running the
rehabilitation exercise classes.
4. To assess the feasibility and acceptability of the main
trial components (eg, recruitment procedures,
rehabilitation referral procedures and proposed out-
comes and process measurement tools) and pro-
posed tools for measuring impacts on outcomes and
costs.
Phase 2: pilot study objectives
5. To determine eligibility, consent, recruitment and
retention rates and speed of recruitment.
6. To determine likely contamination across trial arms.
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7. To determine completion rates for proposed out-
comes measurement tools at baseline and follow-up.
8. To provide data for sample size calculation for a
deﬁnitive RCT.
9. To test intervention ﬁdelity according to study
protocol.
10. To assess the extent to which intervention and trial
procedures can be integrated into routine clinical
practice.
11. To conduct a preliminary economic evaluation of
the cancer rehabilitation programme.
METHODS AND ANALYSIS
Design
This is a two-arm pilot RCT with an embedded feasibility
study that will be undertaken as a phased programme of
work comprising intervention testing and feasibility work
(phase 1) and a pilot trial with a process evaluation
(phase 2). An economic evaluation will be carried out
to establish the cost component of this particular inter-
vention. In line with Medical Research Council guidance
on the development and evaluation of complex inter-
ventions24 a preliminary phase is included, which
focuses on intervention reﬁnement and feasibility and a
qualitative process evaluation of the pilot RCT in order
to ensure that both the intervention and trial proce-
dures are optimised and can be incorporated into
routine clinical practice, thus increasing the likelihood
that a full-scale trial will generate the desired out-
comes.25 The study will be conducted according to
recommendations for good practice in pilot studies.26
Setting
The study will be conducted in three cardiac rehabilita-
tion facilities in three NHS Boards across the UK: NHS
Highland, Highland Heartbeat Centre, Raigmore
Hospital; NHS Wales, University Hospital of Wales and
Maindy Sports Centre, Cardiff; NHS Forth Valley, NHS
Hub at the Peak sports and leisure complex, Stirling.
Participants
Inclusion
1. Adults who have been diagnosed with primary colo-
rectal cancer and are in the recovery period
postsurgery.
2. Patients may be receiving adjunctive chemotherapy/
radiotherapy. Patients must wait 48 h postchemother-
apy before taking part in the intervention.
Exclusion
1. Patients with advanced disease.
2. Patients who fail clinical/risk assessment for rehabili-
tation and are deemed unsafe to participate in exer-
cise classes. (According to recent guidelines, those
with severe anaemia should delay exercise and
patients with compromised immune function should
avoid public gyms and exercise classes.27)
3. Patients with severe cognitive impairment and there-
fore are unable to give informed consent to partici-
pate in the study, or are unable to communicate in
English since this is the language used in cardiac
rehabilitation.
Cardiac patients who have attended cardiac rehabilita-
tion classes with patients with bowel cancer, and colorec-
tal cancer and cardiac clinicians involved in the study
will also be included.
Sample size
For the feasibility study (phase 1) 12 patients with colo-
rectal cancer will be recruited to assess the feasibility
and acceptability of the intervention, recruitment pro-
cesses for the trial and study instruments. In addition,
six cardiac patients and six clinicians will also be
recruited to assess the feasibility and acceptability of the
intervention and recruitment processes.
For the pilot RCT (phase 2), a power calculation is
not appropriate as the study does not aim to provide a
deﬁnitive estimate of treatment effect. Rather the aim is
to provide robust estimates of the likely rates of recruit-
ment and retention, and to yield estimates of the vari-
ability of the primary and secondary outcomes to inform
power calculations for a future large-scale trial. The pilot
trial (phase 2) will be used in order to provide a quanti-
tative estimate of the intervention impact (relative to
control) in order to inform the sample size estimation
for a future deﬁnitive trial. For the pilot RCT (phase 2),
over 6 months, we expect 250 patients to be approached
over the three sites. Responses will determine whether it
is possible to recruit patients and also estimate eligibility,
consent, participation and retention rates and speed of
recruitment for a future large-scale trial. Cancer clini-
cians estimate that approximately one-third will be ineli-
gible (eg, have advanced disease) and based on
recruitment to an RCT about physical activity with
patients with cancer in Scotland (27% recruitment
rate)28 and a trial involving patients with colorectal
cancer within 3 months of completing surgery con-
ducted in Canada (35% recruitment rate)29 we estimate
that about a third of eligible patients will consent. Thus,
for the pilot RCT we expect to recruit 66 patients.
Intervention
The intervention is cardiac rehabilitation delivered to
patients with colorectal cancer within a traditional
cardiac rehabilitation programme setting. This consists of
an 8/12 week programme (depending on research site)
to a mixed patient with cardiac issues/ cancer class with
some information (eg, about treatment-related symp-
toms) speciﬁcally tailored to the different patient groups.
Classes will be delivered once or twice a week, and consist
of 60–90 min of aerobic and strength training and educa-
tional sessions, delivered by a range of health profes-
sionals (the speciﬁc components of the exercise and
educational sessions may be variable depending on
research site). Educational sessions will either be
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delivered to a group of patients with cancer separately
from the cardiac patients (eg, sessions discussing speciﬁc
drug treatments) or one-to-one by telephone (depending
on research site). Participants will set individual physical
activity goals with advice and support from the physio-
therapist. Cardiac physiotherapists will pragmatically
apply underpinning health behaviour theories by, for
instance, discussing barriers to engaging in physical activ-
ity with patients and goal setting, which is in line with
current behaviour change theory30–33 and cardiac
rehabilitation guidance34 to encourage translation of
knowledge into behaviour change. To optimise interven-
tion ﬁdelity, professionals delivering the intervention will
be expected to follow their site-speciﬁc rehabilitation pro-
gramme. Patients randomised to the control arm of the
pilot RCT (phase 2 of the study) will receive ‘Staying
healthy after bowel cancer’ booklet by Bowel Cancer UK,
which includes a section on ‘staying ﬁt’.35
Outcomes
Primary outcome
Physical activity will be assessed using the Actigraph
GT1M accelerometer (Actigraph LLC, Pensacola,
Florida, USA).36–38 Participants will be asked to wear an
accelerometer for 7 days on three occasions (T0—
before patients are randomised to the intervention or
control group; T1—at the end of the intervention (data
will be collected 12 weeks after baseline for patients in
the control arm); and T2—3 months later). Physical
activity will also be assessed subjectively using the
Scottish Physical Activity Questionnaire.39
Secondary outcomes
The proposed secondary outcomes in a future
large-scale trial will be the difference in measures of
quality of life, anxiety and depression and fatigue
between the intervention and usual care (control)
group. Data on these will be collected in the proposed
feasibility study and pilot trial.
Quality of life: EQ-5D, which is a parsimonious measure
of health-related quality of life consisting of ﬁve dimen-
sions: mobility, self-care, usual activities, pain/discom-
fort, anxiety/depression, will be used to measure quality
of life.40 A recent review shows a substantial and growing
body of literature using the EQ-5D in cancer, and draws
the conclusion that it is a valid and reliable instru-
ment.41 The Functional Assessment of Cancer
Therapy-Colorectal (FACT-C) quality of life instrument,
which combines speciﬁc concerns related to colorectal
cancer with concerns that are common to all patients
with cancer will also be used.42
Anxiety and depression: The Hospital Anxiety and
Depression Scale (HADS), which consists of 14 ques-
tions, 7 for anxiety and 7 for depression, will be used to
measure anxiety and depression.43 A meta-analysis sug-
gests that it is sufﬁciently sensitive for identifying depres-
sion and anxiety in patients with cancer.44
Fatigue: The Functional Assessment of Cancer Therapy
Fatigue (FACT-F),45 which is a 13-item fatigue FACT sub-
scale, will be used to measure cancer-related fatigue.
Process variables
Physical activity self-efﬁcacy and risk perception will be mea-
sured to assess if these psychological constructs predict
attendance at cardiac rehabilitation classes and changes
in health outcomes arising from the intervention.
Physical exercise self-efﬁcacy is the belief that one can
engage in, and meet physical activity goals. According to
the behaviour motivation hypothesis,46 perceived risk is
positively and directly related to health behaviour. Risk
perception of suffering from diseases has been found to
play an important role in the development of intentions
to perform physical activity among older adults47 and in
explaining cancer-related behaviours.48
Clinical variables
In addition, the following clinical confounding factors
will be assessed: colon or rectal surgery; surgical inter-
vention (eg, laparoscopic or open surgery); temporary
(a loop ileostomy) or permanent stoma or no stoma;
chemotherapy or no chemotherapy (including duration
and type of chemotherapy); any radiotherapy
treatments.
Feasibility study (phase 1): recruitment, consent and data
collection
Recruitment dates
Recruitment for phase 1 is between 1 July 2013 and 31
December 2013.
Phase 1: recruitment and consent
Patients with Cancer: The following recruitment methods
will be employed in phase 1 for patients with colorectal
cancer. First, a colorectal cancer clinical nurse specialist
will screen all patients with colorectal cancer admitted
for surgery to assess their eligibility for the study. The
nurse will give eligible patients an information sheet
about the study and talk them through it. If the patient
agrees to participate the nurse will ask them to sign a
consent form and then refer the patient to the
researcher who will then inform cardiac rehabilitation
about the patient by email, fax or letter. Patients who
decline to participate having read the study information
will be asked if they would be willing to complete a ques-
tionnaire about reasons for declining to participate.
Second, a member of the cardiac multidisciplinary team
(eg, cardiac physiotherapist or nurse) will contact
patients with cancer and invite them to attend a cardiac
rehabilitation clinical/risk stratiﬁcation assessment to
determine whether the patient will be able to safely exer-
cise from a cardiac clinical perspective and plan physical
activity goals tailored to individual patient needs.
Patients who are deemed safe to exercise will be invited
to attend cardiac rehabilitation classes. Patients who
decline to attend a clinical/risk stratiﬁcation assessment
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will be asked if they would be willing to complete a ques-
tionnaire about reasons for declining to participate.
Cardiac patients: All cardiac patients will be informed
that the study is taking place at the cardiac rehabilitation
facility and that the classes that they attend may include
patients with cancer. At the end of the intervention, six
cardiac patients who attended rehabilitation classes at
the same time as patients with cancer will be
approached by a researcher and invited to attend a semi-
structured face-to-face interview about their experiences
of having patients with cancer participate in rehabilita-
tion. Patients will be purposively sampled so that the
study includes responses from younger and older men
and women.
Clinicians: Cancer and cardiac clinicians involved in
screening and recruitment and/or delivering the inter-
vention will be approached by a researcher and invited
to attend a semistructured face-to-face interview about
their experiences of the trial procedures and the
intervention.
Phase 1: Data collection
A screening and recruitment log will be completed by a
researcher to document all patients considered for the
study and subsequently included or excluded at each
stage of the recruitment process and reasons given. This
will include information such as when the patient was
given information about the study, referred to cardiac
rehabilitation, attended for clinical/risk assessment and
received an offer to attend rehabilitation classes. During
the cancer patient’s attendance of the cardiac rehabilita-
tion programme, a researcher will contact the patient
each week to complete an intervention record log that
will document the number of classes attended by partici-
pants, type and duration of exercises and which educa-
tion classes the patient attended. On completion of
rehabilitation, semistructured face-to-face interviews will
be conducted with, (1) 12 patients with cancer and a
nominated family member, (2) 6 cardiac clinicians who
were involved in screening, recruitment, referral and/or
delivering the intervention and (3) 6 cardiac patients
involved in the mixed cancer/cardiac patient rehabilita-
tion classes, in order to gather responses about the
acceptability of the intervention and trial procedures.
A recruitment ﬂow chart will be produced to identify
patient numbers throughout the recruitment process.
Outcome measures will be taken at baseline and on
immediate completion of the intervention.
Phase 2 pilot RCT: recruitment, randomisation and data
collection
Recruitment dates
Recruitment for phase 2 is between 1 January 2014 and
30 June 2014.
Phase 2: Recruitment and consent
Screening and recruitment of patients with cancer by
clinicians for the pilot trial will follow the same
procedures as outlined for the feasibility study (phase
1), which are described above.
Phase 2: Randomisation
Patients will be randomised to the intervention or
control group after they have consented to participating
in the study and after baseline primary and secondary
measures have been collected. Randomisation with strati-
ﬁcation by centre will be conducted by Tayside Clinical
Trials Unit.
Phase 2: Data collection
As in phase 1, a screening and recruitment log will be
completed by a researcher to document all patients con-
sidered for the study and subsequently included or
excluded at each stage of the recruitment process and
reasons given and a researcher will contact the patient
each week to complete an intervention record log. On
completion of rehabilitation, semistructured face-to-face
interviews will be conducted with 24 patients with
cancer with equal split between research sites to gather
responses about the acceptability of the intervention
and trial procedures. Twelve clinicians involved in
recruitment and/or delivering the intervention split
between the research sites will also be interviewed.
Outcome measures will be collected at baseline, on com-
pletion of the intervention, and at 3 month follow-up.
Analysis
All qualitative data will be analysed in order to address
objectives 1–4 and 10. Audiorecorded interviews will be
transcribed verbatim. Transcripts will be analysed the-
matically using the framework approach,49 which is a
rigorous method that provides a structure within which
qualitative data are organised and themes within and
between groups of participants (eg, between patients
and clinicians) are identiﬁed. Inter-rater reliability will
be performed between the researchers conducting ana-
lysis. Quantitative data will generate the following: esti-
mates of eligibility, consent, recruitment and retention
rates and speed of recruitment (objective 5); estimates of
completion rates of study assessment tools (objective 7);
estimates of contamination between intervention and
control groups (objective 6); estimates of intervention
ﬁdelity (objective 9). Descriptive presentations of the
proposed primary and secondary outcomes will also be
made to inform a sample size calculation for a
large-scale trial and decisions as to whether their inclu-
sion would be informative in a future trial (objective 8).
Finally, comparisons between intervention sites on
recruitment, retention and likely health outcomes, etc
will be made to inform development of intervention and
main trial components for a future large-scale trial.
Economic evaluation
Following previous research on the economics of cardiac
rehabilitation,50 the economic evaluation will involve
three main components: assessment of costs of the
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rehabilitation programme itself; estimation of further
impacts on healthcare use; and bringing these two ele-
ments of cost together with data on outcomes described
above. NHS programme costs will be estimated on a per
patient basis as the sum of costs of space rental, equip-
ment (amortised over usual estimates of life cycles for
such items), staff costs (using NHS wage rates in pro-
gramme sites) and other programme consumable items
(such as rehabilitation literature, again to be estimated
from cost data at local programme sites). At local pro-
gramme sites, ﬁnancial records will be examined as well
as interviews with ﬁnance and care staff, in order to
assess actual impacts of providing the programme on the
costs listed above—space and equipment provision, staff
costs and any consumable items used. These data will
also provide a basis for making further assumptions
about cost impacts in other geographical locations.
Information to be obtained on patient-borne costs will
be obtained by embedding questions in the data collec-
tion instrument. This will cover: distances travelled;
transportation types; shoes, clothing and other equip-
ment purchased to participate; child care expenses; and
total time attending the programme. Where relevant,
patients will be asked to estimate actual monetary costs
incurred by them for using or purchasing these items,
but otherwise will impute data on prices of such items
where respondents cannot recollect monetary amounts.
In addition, at each assessment with intervention and
usual care groups, information will be collected on:
general practitioner visits; hospital emergency depart-
ment visits and hospital admissions; visits to allied health
departments such as physiotherapy and occupational
therapy, nutrition, social work and vocational rehabilita-
tion (from patient questionnaire). Patients will also be
asked to report on any medications used. Data on hos-
pital visits and drug use will also be available through
NHS records. Data on rehabilitation programme costs
and those on further impacts will be aggregated and the
statistical signiﬁcance of differences in cost per patient
between intervention and control group assessed by
appropriate methods depending on the distributional
characteristics of the data.
ETHICS AND DISSEMINATION
Recent policy recommends that cancer rehabilitation is
speciﬁed in Service Level Agreements in commissioning
contracts51 and government cancer strategies recom-
mend rehabilitation.52 53 Yet, rehabilitation is not strongly
articulated in commissioning and local cancer care path-
ways often do not explicitly refer to rehabilitation.
Research to examine how the NHS might improve deliv-
ery of rehabilitation services to effectively and efﬁciently
aid the recovery of patients with cancer will help to
address this gap. In developing this proposal, particular
attention has been paid to addressing a current gap in
service provision: the lack of a sustainable and cost-
effective cancer rehabilitation NHS service capable of
being integrated into the routine follow-up care of
people affected by cancer. The proposed work is novel in
that it aims to test an existing, evidence-based and theory
driven cardiac rehabilitation service for patients with
colorectal cancer. Should this model of rehabilitation
prove to be clinically and cost effective in a future deﬁni-
tive RCT, then referral pathways could be adapted to
ensure that the model is integrated into existing cancer
service frameworks. The future study is likely to be of par-
ticular interest and use to service commissioners and
NHS cancer managers. However, it is important that the
feasibility and acceptability of the proposed intervention
and trial procedures are established ﬁrst before moving
to a full deﬁnitive trial; hence, this pilot RCTwith embed-
ded feasibility study is currently being conducted.
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